• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A freeze-fracture transmission electron microscopy and small angle x-ray diffraction study of the effects of albumin, serum, and polymers on clinical lung surfactant microstructure.白蛋白、血清和聚合物对临床肺表面活性剂微观结构影响的冷冻断裂透射电子显微镜和小角X射线衍射研究
Biophys J. 2007 Jul 1;93(1):123-39. doi: 10.1529/biophysj.106.095513. Epub 2007 Apr 6.
2
Inactivation of pulmonary surfactant due to serum-inhibited adsorption and reversal by hydrophilic polymers: experimental.血清抑制吸附导致肺表面活性物质失活及亲水性聚合物的逆转:实验研究
Biophys J. 2005 Sep;89(3):1769-79. doi: 10.1529/biophysj.105.062620. Epub 2005 May 27.
3
Bilayer aggregate microstructure determines viscoelasticity of lung surfactant suspensions.双层聚集微观结构决定肺表面活性剂悬浮液的粘弹性。
Soft Matter. 2021 May 26;17(20):5170-5182. doi: 10.1039/d1sm00337b.
4
Pulmonary surfactant adsorption is increased by hyaluronan or polyethylene glycol.透明质酸或聚乙二醇可增加肺表面活性物质的吸附。
Colloids Surf B Biointerfaces. 2008 Apr 1;62(2):243-9. doi: 10.1016/j.colsurfb.2007.10.009. Epub 2007 Oct 24.
5
Kinematic viscosity of therapeutic pulmonary surfactants with added polymers.添加聚合物的治疗性肺表面活性剂的运动粘度。
Biochim Biophys Acta. 2009 Mar;1788(3):632-7. doi: 10.1016/j.bbamem.2009.01.005.
6
Properties of mixed monolayers of clinical lung surfactant, serum albumin and hydrophilic polymers.临床肺表面活性剂、血清白蛋白和亲水性聚合物混合单层膜的性质。
Colloids Surf B Biointerfaces. 2013 Jan 1;101:135-42. doi: 10.1016/j.colsurfb.2012.05.038. Epub 2012 Jun 15.
7
Hyaluronan with dextran added to therapeutic lung surfactants improves effectiveness in vitro and in vivo.添加右旋糖酐的透明质酸可提高治疗性肺表面活性剂在体外和体内的有效性。
Exp Lung Res. 2013 May-Jun;39(4-5):191-200. doi: 10.3109/01902148.2013.791893. Epub 2013 May 3.
8
Overcoming rapid inactivation of lung surfactant: analogies between competitive adsorption and colloid stability.克服肺表面活性剂的快速失活:竞争性吸附与胶体稳定性之间的类比
Biochim Biophys Acta. 2010 Apr;1798(4):801-28. doi: 10.1016/j.bbamem.2009.12.010. Epub 2009 Dec 22.
9
Inhibition of pulmonary surfactant adsorption by serum and the mechanisms of reversal by hydrophilic polymers: theory.血清对肺表面活性物质吸附的抑制作用及亲水性聚合物的逆转机制:理论
Biophys J. 2005 Sep;89(3):1621-9. doi: 10.1529/biophysj.105.062646. Epub 2005 Jul 8.
10
Competitive adsorption: a physical model for lung surfactant inactivation.竞争性吸附:肺表面活性剂失活的物理模型。
Langmuir. 2009 Jul 21;25(14):8131-43. doi: 10.1021/la8039434.

引用本文的文献

1
Thermodynamic and Structural Study of Budesonide-Exogenous Lung Surfactant System.布地奈德-外源性肺表面活性剂系统的热力学与结构研究
Int J Mol Sci. 2024 Mar 4;25(5):2990. doi: 10.3390/ijms25052990.
2
Lung surfactant as a biophysical assay for inhalation toxicology.肺表面活性剂作为吸入毒理学的生物物理检测方法。
Curr Res Toxicol. 2022 Dec 23;4:100101. doi: 10.1016/j.crtox.2022.100101. eCollection 2023.
3
Reply to the 'Comment on "Bilayer aggregate microstructure determines viscoelasticity of lung surfactant suspensions"' by J.-F. Berret, DOI: 10.1039/d2sm00653g.回复 J.-F. Berret 的评论“双层聚集微观结构决定肺表面活性剂悬浮液的粘弹性”,DOI: 10.1039/d2sm00653g。
Soft Matter. 2022 Nov 16;18(44):8520-8523. doi: 10.1039/d2sm01142e.
4
Bilayer aggregate microstructure determines viscoelasticity of lung surfactant suspensions.双层聚集微观结构决定肺表面活性剂悬浮液的粘弹性。
Soft Matter. 2021 May 26;17(20):5170-5182. doi: 10.1039/d1sm00337b.
5
The Perturbation of Pulmonary Surfactant by Bacterial Lipopolysaccharide and Its Reversal by Polymyxin B: Function and Structure.细菌脂多糖对肺表面活性剂的干扰及其被多黏菌素 B 的逆转:功能与结构。
Int J Mol Sci. 2018 Jul 5;19(7):1964. doi: 10.3390/ijms19071964.
6
Seventy-Five Years of Research on Protein Binding.七十五年来的蛋白质结合研究。
Antimicrob Agents Chemother. 2018 Jan 25;62(2). doi: 10.1128/AAC.01663-17. Print 2018 Feb.
7
Pneumocytes Assemble Lung Surfactant as Highly Packed/Dehydrated States with Optimal Surface Activity.肺细胞将肺表面活性物质组装成具有最佳表面活性的高度密集/脱水状态。
Biophys J. 2015 Dec 1;109(11):2295-306. doi: 10.1016/j.bpj.2015.10.022.
8
Effect of cholesterol nanodomains on monolayer morphology and dynamics.胆固醇纳米域对单层形态和动力学的影响。
Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):E3054-60. doi: 10.1073/pnas.1303304110. Epub 2013 Jul 30.
9
Lung surfactant microbubbles increase lipophilic drug payload for ultrasound-targeted delivery.肺表面活性剂微泡增加亲脂性药物的载药量,用于超声靶向给药。
Theranostics. 2013 May 20;3(6):409-19. doi: 10.7150/thno.5616. Print 2013.
10
Role of airway recruitment and derecruitment in lung injury.气道复张和去复张在肺损伤中的作用。
Crit Rev Biomed Eng. 2011;39(4):297-317. doi: 10.1615/critrevbiomedeng.v39.i4.40.

本文引用的文献

1
Enhanced surfactant adsorption via polymer depletion forces: a simple model for reversing surfactant inhibition in acute respiratory distress syndrome.通过聚合物耗尽力增强表面活性剂吸附:一种逆转急性呼吸窘迫综合征中表面活性剂抑制作用的简单模型
Biophys J. 2007 Jan 1;92(1):3-9. doi: 10.1529/biophysj.106.091157. Epub 2006 Oct 13.
2
Chitosan enhances the in vitro surface activity of dilute lung surfactant preparations and resists albumin-induced inactivation.壳聚糖可增强稀释肺表面活性剂制剂的体外表面活性,并抵抗白蛋白诱导的失活。
Pediatr Res. 2006 Aug;60(2):125-30. doi: 10.1203/01.pdr.0000227558.14024.57.
3
Morphological alterations of exogenous surfactant inhibited by meconium can be prevented by dextran.葡聚糖可预防胎粪抑制的外源性表面活性剂的形态学改变。
Respir Res. 2006 Jun 6;7(1):86. doi: 10.1186/1465-9921-7-86.
4
Zero spontaneous curvature and its effects on lamellar phase morphology and vesicle size distributions.零自发曲率及其对层状相形态和囊泡尺寸分布的影响。
Langmuir. 2006 Mar 14;22(6):2474-81. doi: 10.1021/la052448p.
5
Hyaluronan reduces surfactant inhibition and improves rat lung function after meconium injury.透明质酸可减轻胎粪吸入损伤后表面活性剂的抑制作用并改善大鼠肺功能。
Pediatr Res. 2005 Aug;58(2):206-10. doi: 10.1203/01.PDR.0000169981.06266.3E. Epub 2005 Jul 31.
6
Aerosolized hyaluronan limits airspace enlargement in a mouse model of cigarette smoke-induced pulmonary emphysema.雾化透明质酸可限制香烟烟雾诱导的小鼠肺气肿模型中的气腔扩大。
Exp Lung Res. 2005 May;31(4):417-30. doi: 10.1080/01902140590918669.
7
Inhibition of pulmonary surfactant adsorption by serum and the mechanisms of reversal by hydrophilic polymers: theory.血清对肺表面活性物质吸附的抑制作用及亲水性聚合物的逆转机制:理论
Biophys J. 2005 Sep;89(3):1621-9. doi: 10.1529/biophysj.105.062646. Epub 2005 Jul 8.
8
Inactivation of pulmonary surfactant due to serum-inhibited adsorption and reversal by hydrophilic polymers: experimental.血清抑制吸附导致肺表面活性物质失活及亲水性聚合物的逆转:实验研究
Biophys J. 2005 Sep;89(3):1769-79. doi: 10.1529/biophysj.105.062620. Epub 2005 May 27.
9
Overview of surfactant replacement trials.表面活性剂替代试验概述。
J Perinatol. 2005 May;25 Suppl 2:S40-4. doi: 10.1038/sj.jp.7211320.
10
Dextran or polyethylene glycol added to curosurf for treatment of meconium lung injury in rats.
Biol Neonate. 2005;88(1):46-53. doi: 10.1159/000084458. Epub 2005 Mar 14.

白蛋白、血清和聚合物对临床肺表面活性剂微观结构影响的冷冻断裂透射电子显微镜和小角X射线衍射研究

A freeze-fracture transmission electron microscopy and small angle x-ray diffraction study of the effects of albumin, serum, and polymers on clinical lung surfactant microstructure.

作者信息

Braun Andreas, Stenger Patrick C, Warriner Heidi E, Zasadzinski Joseph A, Lu Karen W, Taeusch H William

机构信息

Department of Chemical Engineering, University of California, Santa Barbara, California 93106, USA.

出版信息

Biophys J. 2007 Jul 1;93(1):123-39. doi: 10.1529/biophysj.106.095513. Epub 2007 Apr 6.

DOI:10.1529/biophysj.106.095513
PMID:17416614
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1914435/
Abstract

Freeze-fracture transmission electron microscopy shows significant differences in the bilayer organization and fraction of water within the bilayer aggregates of clinical lung surfactants, which increases from Survanta to Curosurf to Infasurf. Albumin and serum inactivate all three clinical surfactants in vitro; addition of the nonionic polymers polyethylene glycol, dextran, or hyaluronic acid also reduces inactivation in all three. Freeze-fracture transmission electron microscopy shows that polyethylene glycol, hyaluronic acid, and albumin do not adsorb to the surfactant aggregates, nor do these macromolecules penetrate the interior water compartments of the surfactant aggregates. This results in an osmotic pressure difference that dehydrates the bilayer aggregates, causing a decrease in the bilayer spacing as shown by small angle x-ray scattering and an increase in the ordering of the bilayers as shown by freeze-fracture electron microscopy. Small angle x-ray diffraction shows that the relationship between the bilayer spacing and the imposed osmotic pressure for Curosurf is a screened electrostatic interaction with a Debye length consistent with the ionic strength of the solution. The variation in surface tension due to surfactant adsorption measured by the pulsating bubble method shows that the extent of surfactant aggregate reorganization does not correlate with the maximum or minimum surface tension achieved with or without serum in the subphase. Albumin, polymers, and their mixtures alter the surfactant aggregate microstructure in the same manner; hence, neither inhibition reversal due to added polymer nor inactivation due to albumin is caused by alterations in surfactant microstructure.

摘要

冷冻断裂透射电子显微镜显示,临床肺表面活性剂双层聚集体的双层组织和双层内水的比例存在显著差异,从固尔苏到珂立苏再到英孚美,这种差异逐渐增大。白蛋白和血清在体外可使所有三种临床表面活性剂失活;添加非离子聚合物聚乙二醇、右旋糖酐或透明质酸也能降低这三种表面活性剂的失活程度。冷冻断裂透射电子显微镜显示,聚乙二醇、透明质酸和白蛋白不会吸附到表面活性剂聚集体上,这些大分子也不会穿透表面活性剂聚集体内部的水相区室。这会导致渗透压差异,使双层聚集体脱水,如小角X射线散射所示,双层间距减小,如冷冻断裂电子显微镜所示,双层的有序性增加。小角X射线衍射显示,珂立苏的双层间距与外加渗透压之间的关系是一种屏蔽静电相互作用,德拜长度与溶液的离子强度一致。用脉动气泡法测量的表面活性剂吸附引起的表面张力变化表明,表面活性剂聚集体的重组程度与在亚相中有无血清时达到的最大或最小表面张力无关。白蛋白、聚合物及其混合物以相同方式改变表面活性剂聚集体的微观结构;因此,添加聚合物导致的抑制逆转或白蛋白导致的失活都不是由表面活性剂微观结构的改变引起的。